Asia-Pacific Cell-based Assays Market - Industry Trends and Forecast to 2026

Asia-Pacific Cell-based Assays Market - Industry Trends and Forecast to 2026

Short Description

By Type (Cell Viability Assay, Cytotoxicity Assay, Cell Death Assay, Cell Proliferation Assay, Others), Product & Services (Consumables, Services, Instruments and Software), Technology (Flow Cytometry, High Throughput Screening, High Content Screening, Label Free Detection), Application (Drug Discovery, Basic Research, Others), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutions, Government Organizations, Others), Distribution Channel (Direct, Indirect), Country (China, Japan, South Korea, India, Singapore, Australia, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific).
Market Definition:
Cell-based assays are basically used for biological testing such as potency and mechanism of action of drug product. Cell-based assays are the method to study living cell by considering different parameters such as pharmacokinetic study and pharmacodynamics study. Cell viability assay is expected to dominate global cell based assays with the increasing demand for measuring cellular metabolism and enzyme activity.
Cell-based assays are basically in-vitro assays which helps in the drug development process. It is used for cytotoxic testing, determination of actual potency of drug product and drug substances and for the determination of mechanism of action of drug substances. It can be of different types such as cell viability assays, cell proliferation assays and cell death assays.
Market Segmentation:
The Asia-Pacific cell based assays market is segmented into six notable segments which are on the basis of by type, product and services, technology, application, end user and distribution channel.
• On the basis of type, the market is segmented into cell viability assay, cell proliferation assay, cytotoxicity assay, cell death assay, others.
• On the basis of product and services, the market is segmented consumables, services, instruments and software.
• On the basis of technology, the market is segmented into flow cytometry, label free detection, high content screening, high throughput screening.
• On the basis of application, the market is segmented into drug discovery, basic research, others.
• On the basis of end-user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutions, contract research organizations, government organizations and others.
• On the basis of distribution channel, the market is segmented into direct and indirect.
Market Players
The key market players for Asia-Pacific cell based assays market are listed below:
• Danaher
• Agilent Technologies, Inc.
• Thermo Fisher Scientific Inc.
• Merck KGaA
• PerkinElmer Inc.
• Bio-Rad Laboratories, Inc.
• Aurelia Bioscience Ltd
• BD
• BioAgilytix Labs
• BioVision Inc.
• Cell Signaling Technology, Inc
• Cisbio
• Enzo Biochem Inc
• Eurofins Scientific
• LakePharma, Inc
• Lonza
• Miltenyi Biotec
• XenoDiagnostics, LLCPlease Note: The single user license is non-downloadable and non-printable. Global Site license allows these actions.

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Asia-pacific Cell Based Assays Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Asia-pacific Cell Based Assays Market: Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Primary Interviews With Key Opinion Leaders
2.7 Dbmr Market Position Grid (On The Basis Of Products)
2.8 Dbmr Market Position Grid
2.9 Dbmr Vendor Share Analysis
2.10 Multivariate Modeling
2.11 Products Lifeline Curve
2.12 Secondary Sources
2.13 Assumptions
3 Market Overview
3.1 Drivers
3.1.1 Increasing Incidence Of Chronic Diseases
3.1.2 Rising Demands For Novel Small Molecules, Bio-therapeutic And Cell Based Therapies
3.1.3 Increase In Research And Development Expenditure
3.2 Restraint
3.2.1 Stringent Regulatory Requirements
3.2.2 High Cost Of Instrumentation
3.3 Opportunities
3.3.1 Technological Advancements
3.3.2 Strategic Initiative By The Market Players
3.4 Challenges
3.4.1 Challenging Analysis Procedure
4 Executive Summary
5 Premium Insights
6 Asia-pacific Cell-based Assays Market, By Type
6.1 Overview
6.2 Cell Viability Assay
6.3 Cytotoxicity Assay
6.4 Cell Proliferation Assay
6.5 Cell Death Assay
6.6 Others
7 Asia-pacific Cell-based Assays Market, By Product & Services
7.1 Overview
7.2 Consumables
7.2.1 Assay Kits
7.2.2 Cell Lines Primary Cell Lines Stem Cell Lines Immortalized Cell Lines
7.2.3 Reagents
7.2.4 Microplates
7.3 Services
7.4 Instruments And Software
8 Asia-pacific Cell-based Assays Market, By Technology
8.1 Overview
8.2 High Throughput Screening
8.3 Flow Cytometry
8.4 High Content Screening
8.5 Label Free Detection
9 Asia-pacific Cell-based Assays Market, By Application
9.1 Overview
9.2 Drug Discovery
9.2.1 Predictive Toxicology
9.2.2 Pharmacodynamic Studies
9.2.3 Adme Research
9.3 Basic Research
9.4 Others
10 Asia-pacific Cell-based Assays Market, By End User
10.1 Overview
10.2 Pharmaceutical & Biotechnology Companies
10.3 Contract Research Organizations
10.4 Academic & Research Institutions
10.5 Government Organizations
10.6 Others
11 Asia-pacific Cell-based Assays Market, By Distribution Channel
11.1 Overview
11.2 Direct
11.3 Indirect
12 Asia-pacific Cell Based Assay Market, By Geography
12.1 Asia-pacific
12.1.1 China
12.1.2 Japan
12.1.3 South Korea
12.1.4 India
12.1.5 Singapore
12.1.6 Australia
12.1.7 Thailand
12.1.8 Malaysia
12.1.9 Indonesia
12.1.10 Philippines
12.1.11 Rest Of Asia-pacific
13 Asia-pacific Cell Based Assays Market For Products, Company Landscape
13.1 Company Share Analysis: Asia-pacific
14 Asia-pacific Cell Based Assays Market For Services, Company Landscape
14.1 Company Share Analysis: Asia-pacific
15 Company Profile
15.1 General Electric
15.1.1 Company Snapshot
15.1.2 Revenue Analysis
15.1.3 Company Share Analysis
15.1.4 Product Portfolio
15.1.5 Recent Developments
15.2 Danaher
15.2.1 Company Snapshot
15.2.2 Revenue Analysis
15.2.3 Company Share Analysis
15.2.4 Product Portfolio
15.2.5 Recent Development
15.3 Agilent Technologies, Inc. Company Snapshot
15.3.2 Revenue Analysis
15.3.3 Company Share Analysis
15.3.4 Product Portfolio
15.3.5 Recent Developments
15.4 Thermo Fisher Scientific Inc
15.4.1 Company Snapshot
15.4.2 Revenue Analysis
15.4.3 Company Share Analysis
15.4.4 Product Portfolio
15.4.5 Recent Development
15.5 Merck Kgaa
15.5.1 Company Snapshot
15.5.2 Revenue Analysis
15.5.3 Product Portfolio
15.5.4 Recent Development
15.6 Perkinelmer Inc, Inc.
15.6.1 Company Snapshot
15.6.2 Revenue Analysis
15.6.3 Product Portfolio
15.6.4 Recent Development
15.7 Bio-rad Laboratories, Inc.
15.7.1 Company Snapshot
15.7.2 Revenue Analysis
15.7.3 Product Portfolio
15.7.4 Recent Developments
15.8 Atcc
15.8.1 Company Snapshot
15.8.2 Product Portfolio
15.8.3 Recent Development
15.9 Aurelia Bioscience Ltd.
15.9.1 Company Snapshot
15.9.2 Service Portfolio
15.9.3 Recent Development
15.10 Bd
15.10.1 Company Snapshot
15.10.2 Revenue Analysis
15.10.3 Product Portfolio
15.10.4 Recent Developments
15.11 Bioagilytix Labs
15.11.1 Company Snapshot
15.11.2 Service Portfolio
15.11.3 Recent Developments
15.12 Biovision Inc.
15.12.1 Company Snapshot
15.12.2 Product Portfolio
15.12.3 Recent Development
15.13 Cell Signaling Technology, Inc.
15.13.1 Company Snapshot
15.13.2 Product Portfolio
15.13.3 Recent Development
15.14 Cisbio
15.14.1 Company Snapshot
15.14.2 Product Portfolio
15.14.3 Recent Development
15.15 Enzo Biochem Inc.
15.15.1 Company Snapshot
15.15.2 Revenue Analysis
15.15.3 Product Portfolio
15.15.4 Recent Development
15.16 Eurofins Scientific
15.16.1 Company Snapshot
15.16.2 Revenue Analysis
15.16.3 Product And Service Portfolio
15.16.4 Recent Developments
15.17 Lakepharma, Inc.
15.17.1 Company Snapshot
15.17.2 Service Portfolio
15.17.3 Recent Development
15.18 Lonza
15.18.1 Company Snapshot
15.18.2 Revenue Analysis
15.18.3 Service Portfolio
15.18.4 Recent Development
15.19 Miltenyi Biotec
15.19.1 Company Snapshot Product Portfolio
15.19.3 Recent Development
15.20 Xeno Diagnostics, Llc.
15.20.1 Company Snapshot
15.20.2 Product Portfolio
15.20.3 Recent Development
16 Questionnaire
17 Related Reports

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook